Marker Therapeutics, Inc. (MRKR) stock
MRKRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.87−0.03 (-3.33%)
Close on Nov 13, 2026Market cap $14.51MP/E –Yield –
Marker Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Marker Therapeutics's enterprise value was $4.54M on Nov 11, 2026, against $3.12M a year earlier. Over the last 5 years it ranged from -$15.28M to $38.04M, with a median of $6.81M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.54M | -37.8% |
| 2025 | Dec 31, 2025 | $7.29M | -61.0% |
| 2024 | Dec 31, 2024 | $18.68M | -39.6% |
| 2023 | Dec 29, 2023 | $30.93M | +587.9% |
| 2022 | Dec 30, 2022 | $4.50M | -85.1% |
| 2021 | Dec 31, 2021 | $30.26M | -29.0% |
| 2020 | Dec 31, 2020 | $42.64M | -48.7% |
| 2019 | Dec 31, 2019 | $83.14M | +22.8% |
| 2018 | Dec 31, 2018 | $67.70M | +101.8% |
| 2017 | Dec 29, 2017 | $33.55M | +46.0% |
| 2016 | Dec 30, 2016 | $22.99M | +26.8% |
| 2015 | Dec 31, 2015 | $18.13M | +317.4% |
| 2014 | Dec 31, 2014 | $4.34M | -98.5% |
| 2013 | Dec 31, 2013 | $288.61M | -67.4% |
| 2012 | Dec 31, 2012 | $886.51M | +24.8% |
| 2011 | Dec 30, 2011 | $710.48M | – |
See a number that looks wrong?